marketinference1d
Understanding the Tailwind Behind DexCom Shares.
One of the standouts of today's afternoon trading session was DexCom, which logged a 6.4% performance and outperformed the S&P 500 by 6.0%. The Medical Instruments & Supplies stock is now trading at ...
marketinference2d
Minerals Technologies Completes Debt Refinancing
Minerals Technologies Inc. (MTI) has successfully completed a significant debt refinancing, as announced in a recent press release. The company closed a new seven-year $575 million senior secured Term ...
marketinference2d
KalVista Pharmaceuticals Appoints Laurence Reid, Ph.D., to Board
Kalvista Pharmaceuticals, Inc. (NASDAQ: KALV) has appointed Laurence Reid, Ph.D., to its board of directors, effective immediately. Dr. Reid's appointment brings more than three decades of experience ...
marketinference2d
Analyzing Market Sentiment Towards Coinbase Global (COIN) Stocks
Coinbase Global's short interest — meaning the percentage of the share float that is being shorted — is lower than average at ...
marketinference2d
Keros Therapeutics CEO to Present at Healthcare Conferences
Keros Therapeutics, Inc. has recently announced its participation in two upcoming healthcare conferences. The company's Chair ...
marketinference2d
Select Medical Distributes 81.7% of Concentra Stock
Following the completion of the spin-off of Concentra, Select Medical Holdings Corporation announced that it has distributed ...
marketinference2d
PennantPark Floating Rate Capital's 10-K Report Insights
In the recently released 10-K report, PennantPark Floating Rate Capital discussed forward-looking statements, highlighting ...
marketinference2d
Decoding the Momentum Driving Constellation Energy Stock.
Constellation Energy's short interest — meaning the percentage of the share float that is being shorted — is lower than ...
marketinference2d
Investors Are Bullish on Arista Networks - Here's What You Need to Know.
Despite today's 2.7% jump to $410.43, Arista Networks may soon be running into resistance as it is now within range of its average analyst target price of $427.39. With an average rating of buy, and ...
marketinference2d
Briefing on the Fundamentals of Viking Therapeutics
Viking Therapeutics marked a 5.7% change today, compared to 0.0% for the S&P 500. Is it a good value at today's price of $54.97? Only an in-depth analysis can answer that question, but here are some ...
marketinference2d
Why Are People Talking About Investing in STZ?
Constellation Brands sank -4.0% today, compared to the S&P 500's day change of 0.0%. Today's losers may turn out to be tomorrow's winners, so be sure to check the stock's fundamentals before making an ...
marketinference2d
D.R. Horton Stock Surges – Is It Overheating?
One of Wall Street's biggest winners of the day is D.R. Horton, a residential construction company whose shares have climbed 6.4% to a price of $174.04 -- 8.38% below its average analyst target price ...